Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander C Walsh

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
The British Journal of Ophthalmology|July 8, 2011
Comparison of manually corrected retinal thickness measurements from multiple spectral-domain optical coherence tomography instrumentsFlorian M Heussen, Yanling Ouyang, Emma C McDonnell, et al.
European Journal of Ophthalmology|July 22, 2014
Effect of anti-VEGF treatment on choroidal thickness over time in patients with neovascular age-related macular degenerationEmma C McDonnell, Florian M Heussen, Humberto Ruiz-Garcia, et al.
Investigative Ophthalmology & Visual Science|June 21, 2011
Relationship between outer retinal thickness substructures and visual acuity in eyes with dry age-related macular degenerationRajeev R Pappuru, Yanling Ouyang, Muneeswar Gupta Nittala, et al.
Investigative Ophthalmology & Visual Science|January 28, 2012
Assessment of differential pharmacodynamic effects using optical coherence tomography in neovascular age-related macular degenerationPearse A Keane, Florian M Heussen, Yanling Ouyang, et al.
Investigative Ophthalmology & Visual Science|June 18, 2010
Effects of retinal morphology on contrast sensitivity and reading ability in neovascular age-related macular degenerationPearse A Keane, Praveen J Patel, Yanling Ouyang, et al.
Ophthalmology|July 14, 2007
Quantitative comparison of optical coherence tomography after pegaptanib or bevacizumab in neovascular age-related macular degenerationSandra Joeres, Kevin Kaplowitz, Jacob W Brubaker, et al.
Investigative Ophthalmology & Visual Science|April 15, 2008
Quantitative subanalysis of optical coherence tomography after treatment with ranibizumab for neovascular age-related macular degenerationPearse A Keane, Sandra Liakopoulos, Sharel C Ongchin, et al.
Investigative Ophthalmology & Visual Science|August 29, 2007
Reproducibility of quantitative optical coherence tomography subanalysis in neovascular age-related macular degenerationSandra Joeres, Jerry W Tsong, Paul G Updike, et al.
The British Journal of Ophthalmology|July 28, 2011
Bevacizumab and ranibizumab tachyphylaxis in the treatment of choroidal neovascularisationJulie L Gasperini, Amani A Fawzi, Ani Khondkaryan, et al.
Investigative Ophthalmology & Visual Science|August 4, 2011
Spatial distribution of posterior pole choroidal thickness by spectral domain optical coherence tomographyYanling Ouyang, Florian M Heussen, Nils Mokwa, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
The British Journal of Ophthalmology|July 8, 2011
Comparison of manually corrected retinal thickness measurements from multiple spectral-domain optical coherence tomography instrumentsFlorian M Heussen, Yanling Ouyang, Emma C McDonnell, et al.
European Journal of Ophthalmology|July 22, 2014
Effect of anti-VEGF treatment on choroidal thickness over time in patients with neovascular age-related macular degenerationEmma C McDonnell, Florian M Heussen, Humberto Ruiz-Garcia, et al.
Investigative Ophthalmology & Visual Science|June 21, 2011
Relationship between outer retinal thickness substructures and visual acuity in eyes with dry age-related macular degenerationRajeev R Pappuru, Yanling Ouyang, Muneeswar Gupta Nittala, et al.
Investigative Ophthalmology & Visual Science|January 28, 2012
Assessment of differential pharmacodynamic effects using optical coherence tomography in neovascular age-related macular degenerationPearse A Keane, Florian M Heussen, Yanling Ouyang, et al.
Investigative Ophthalmology & Visual Science|June 18, 2010
Effects of retinal morphology on contrast sensitivity and reading ability in neovascular age-related macular degenerationPearse A Keane, Praveen J Patel, Yanling Ouyang, et al.
Ophthalmology|July 14, 2007
Quantitative comparison of optical coherence tomography after pegaptanib or bevacizumab in neovascular age-related macular degenerationSandra Joeres, Kevin Kaplowitz, Jacob W Brubaker, et al.
Investigative Ophthalmology & Visual Science|April 15, 2008
Quantitative subanalysis of optical coherence tomography after treatment with ranibizumab for neovascular age-related macular degenerationPearse A Keane, Sandra Liakopoulos, Sharel C Ongchin, et al.
Investigative Ophthalmology & Visual Science|August 29, 2007
Reproducibility of quantitative optical coherence tomography subanalysis in neovascular age-related macular degenerationSandra Joeres, Jerry W Tsong, Paul G Updike, et al.
The British Journal of Ophthalmology|July 28, 2011
Bevacizumab and ranibizumab tachyphylaxis in the treatment of choroidal neovascularisationJulie L Gasperini, Amani A Fawzi, Ani Khondkaryan, et al.
Investigative Ophthalmology & Visual Science|August 4, 2011
Spatial distribution of posterior pole choroidal thickness by spectral domain optical coherence tomographyYanling Ouyang, Florian M Heussen, Nils Mokwa, et al.
Pageof 4